Cargando…

TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) remains lethal despite the development of numerous drug therapy technologies. About 85% to 90% of lung cancers are NSCLC and the 5-year survival rate is at best still below 50%. Thus, it is important to find drugable target genes for NSCLC to develop an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Umeyama, Hideaki, Iwadate, Mitsuo, Taguchi, Y-h
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290609/ https://www.ncbi.nlm.nih.gov/pubmed/25521548 http://dx.doi.org/10.1186/1471-2164-15-S9-S2

Ejemplares similares

SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer
por: Taguchi, Y-h., et al.
Publicado: (2016)

Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets
por: Kinoshita, Ryoichi, et al.
Publicado: (2014)

Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease
por: Taguchi, Y-h, et al.
Publicado: (2015)

Bioinformatic Screening of Autoimmune Disease Genes and Protein Structure Prediction with FAMS for Drug Discovery
por: Ishida, Shigeharu, et al.
Publicado: (2014)

TINAGL1 promotes hepatocellular carcinogenesis through the activation of TGF-β signaling-medicated VEGF expression
por: Sun, Lu, et al.
Publicado: (2019)

Role of GALNT14 in lung metastasis of breast cancer
por: Kim, Mi-Young
Publicado: (2017)

Development of a novel anti-hepatitis B virus agent via Sp1
por: Hayakawa, Michiyo, et al.
Publicado: (2020)

Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1
por: Hayakawa, Michiyo, et al.
Publicado: (2020)

Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling
por: Huang, Miao-Juei, et al.
Publicado: (2015)

High Expression of N-Acetylgalactosaminyltransferase 1 (GALNT1) Associated with Invasion, Metastasis, and Proliferation in Osteosarcoma
por: Zhang, Liwen, et al.
Publicado: (2020)

GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment
por: Song, Ki-Hoon, et al.
Publicado: (2016)

Pan-Cancer Analysis of B4GALNT1 as a Potential Prognostic and Immunological Biomarker
por: Yi, Hang, et al.
Publicado: (2022)

miR-365b regulates the development of non-small cell lung cancer via GALNT4
por: Xing, Lei, et al.
Publicado: (2020)

GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma
por: Ho, Wan-Ling, et al.
Publicado: (2014)

Expression of B4GALNT1, an essential glycosyltransferase for the synthesis of complex gangliosides, suppresses BACE1 degradation and modulates APP processing
por: Yamaguchi, Tokiaki, et al.
Publicado: (2016)

The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancer
por: Hu, Qing, et al.
Publicado: (2022)

lncRNA GAU1 Induces GALNT8 Overexpression and Potentiates Colorectal Cancer Progression
por: Tang, Xuemei, et al.
Publicado: (2021)

The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression
por: Sheta, Razan, et al.
Publicado: (2019)

Galnt1 Is Required for Normal Heart Valve Development and Cardiac Function
por: Tian, E, et al.
Publicado: (2015)

Parkinson’s disease recovery by GM1 oligosaccharide treatment in the B4galnt1(+/−) mouse model
por: Chiricozzi, Elena, et al.
Publicado: (2019)

Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown()
por: Tarhan, Yunus Emre, et al.
Publicado: (2016)

GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78
por: Song, Jing, et al.
Publicado: (2020)

GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway
por: Mao, Yingge, et al.
Publicado: (2019)

GALNT12 promotes fibrosarcoma growth by accelerating YAP1 nuclear localization
por: Yu, Site, et al.
Publicado: (2023)

Expanding the Phenotype of B3GALNT2-Related Disorders
por: D’haenens, Erika, et al.
Publicado: (2022)

LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1
por: Shan, Yujia, et al.
Publicado: (2018)

Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation
por: Liu, Shin-Yun, et al.
Publicado: (2016)

GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway: Erratum
por: Mao, Yingge, et al.
Publicado: (2021)

MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C
por: Liao, Ming, et al.
Publicado: (2020)

GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2017)

miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cells
por: Gaziel-Sovran, Avital, et al.
Publicado: (2012)

miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1
por: Ye, Zaiting, et al.
Publicado: (2017)

Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer
por: Fu, Zhiwen, et al.
Publicado: (2022)

GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M
por: Liu, Chang, et al.
Publicado: (2020)

Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
por: Harlalka, Gaurav V., et al.
Publicado: (2013)

New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma
por: Costa, Valerio, et al.
Publicado: (2015)

Role of GALNT4 in protecting against cardiac hypertrophy through ASK1 signaling pathway
por: Zhang, Bin-Bin, et al.
Publicado: (2021)

B4GALNT2 and xenotransplantation: A newly appreciated xenogeneic antigen
por: Byrne, Guerard, et al.
Publicado: (2018)

miR-4262 inhibits colon cancer cell proliferation via targeting of GALNT4
por: Qu, Jian-Jun, et al.
Publicado: (2017)

Identification of GALNT14 as a novel neuroblastoma predisposition gene
por: De Mariano, Marilena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v0jlpecqki7g7eskgo0h08u8qk